Latest Developments and Insights
![](https://synergbiopharma.com/wp-content/uploads/2024/06/Featured-image-syner-g-768x390.jpg)
Syner-G’s Medical Writing Fellowship Program: Preparing Professionals for a Career in Regulatory Medical Writing
February 16, 2024 | Yash Patel, PharmD, Yamini Purohit, PhD, and Kelsey Gray, PhD – Medical Writing Fellows | Medical Writing Services Regulatory medical writers play a key role in facilitating the development and compilation of documents that are…
Read Full Article
![](https://synergbiopharma.com/wp-content/uploads/2024/06/Featured-image-syner-g-768x390.jpg)
Useful Tools to Facilitate CDMO Selection Process for Biologics
Selecting a Contract Development and Marketing Organization (CDMO) is not a new topic, and much has been written and learned since CDMO’s first started to become an option in the late 1990s. If the decision is to outsource, selecting a…
Read Full Article
![](https://synergbiopharma.com/wp-content/uploads/2024/06/Featured-image-syner-g-768x390.jpg)
Advice for First Time NDA/BLA Submission Teams
Our team of medical writers has worked with many clients on marketing applications (e.g., NDA, ANDA, BLA, or MAA) across a variety of therapeutic areas. Each submission is a challenge in its own unique way, but we have found…
Read Full Article
![](https://synergbiopharma.com/wp-content/uploads/2024/06/Featured-image-syner-g-768x390.jpg)
Regulatory Medical Writing: Who is your audience?
Whether it’s a clinical study report (CSR) for a single clinical study or a Clinical Overview that summarizes a complex clinical development program, it’s often best to consider who you’re writing for at the very start of a writing…
Read Full Article
![](https://synergbiopharma.com/wp-content/uploads/2024/06/Featured-image-syner-g-768x390.jpg)
How to Choose a Partner to Optimize INDs
Biopharmaceutical development is an extensive and complex process. Managing processes like Investigational New Drug (IND) applications or the manufacturing, quality, and regulatory side of the processes—collectively known as CMC, or the Chemistry, Manufacturing and Controls—requires a highly skilled team with…
Read Full Article
![](https://synergbiopharma.com/wp-content/uploads/2024/06/Featured-image-syner-g-768x390.jpg)
Four Top Roadblocks to Successful IND Applications and How to Overcome Them
Bringing a new drug to market is a complex process that can take years with no guarantee of a successful outcome. The journey is highly regulated and includes numerous processes that require drug developers to have multiple levels of expertise…